Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ana F Vega-Benedetti1, Cinthia N Saucedo1, Patrizia Zavattari2

  • 1Institute of Experimental Pathology, CONICET-UNSa, Salta, Argentina.

Oncotarget
|September 15, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monocarboxylate transporter 2 regulates maintenance of myelin and axonal integrity by oligodendrocytes.

Nature communications·2026
Same author

MicroRNAs in exhaled breath condensate and plasma for diagnosis of asbestos-related interstitial lung diseases.

Expert review of respiratory medicine·2026
Same author

Heparan Sulphate Glycosaminoglycan Chains Contribute to the Tethering of Coronal Factors and Are Important for Extracellular Vesicle-Mediated Fibroblast Activation.

Journal of extracellular biology·2026
Same author

Elevated serum trimethylamine N-oxide (TMAO) and trimethyllysine in patients with amyotrophic lateral sclerosis (ALS): An exploratory case-control study.

IBRO neuroscience reports·2026
Same author

Hypoxia-inducible factor-1: A new neuroprotective agent for the treatment of hyperglycemia after stroke.

Neural regeneration research·2026
Same author

DNA Methylation in macrophages infected with <i>Leishmania</i> spp. in different culture conditions.

Emerging microbes & infections·2025
Same journal

Retraction: Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression.

Oncotarget·2026
Same journal

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer.

Oncotarget·2026
Same journal

Retraction: MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.

Oncotarget·2026
Same journal

Laryngeal leiomyosarcoma: A rare case report and literature review.

Oncotarget·2026
Same journal

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Oncotarget·2026
Same journal

DHHC3 interferes with antitumor immunity in melanoma cells.

Oncotarget·2026
See all related articles

Hepatocellular carcinoma involves cell cycle deregulation. The PLAGL1 gene

Area of Science:

  • Molecular biology
  • Cancer research
  • Hepatocellular carcinoma

Background:

  • Hepatocellular carcinoma (HCC) is a multistep process characterized by cell cycle deregulation and uncontrolled proliferation.
  • The PLAGL1 gene encodes a zinc finger protein crucial for regulating cell proliferation.
  • Understanding PLAGL1's role in HCC pathogenesis is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the genomic profile, transcription, and expression levels of PLAGL1 and its partners (p53, PPARγ, p21) in liver cancer cell lines.
  • To explore the relationship between PLAGL1 gene activity and protein expression during hepatocarcinogenesis.
  • To examine the coordinated transcription of PLAGL1 and p53 in normal versus cancer cells.

Main Methods:

  • Analysis of genomic and epigenetic profiles of PLAGL1 in hepatoma cell lines.
Keywords:
PLAGL1cell proliferationchromosomehepatocellular carcinomamethylation

Related Experiment Videos

  • Quantitative assessment of PLAGL1, p53, PPARγ, and p21 transcription and protein expression.
  • Reverse transcription-polymerase chain reaction (RT-PCR) to analyze gene transcription in normal fibroblasts and cancer cells.

    • Main Results:

    • Genomic and epigenetic alterations of PLAGL1 were observed in hepatoma cell lines.
    • PLAGL1 transcription was significantly lower in tumor cells compared to normal fibroblasts, but protein levels showed no significant difference.
    • Normal cells exhibit orchestrated PLAGL1 and p53 transcription during proliferation, a process disrupted in cancer cells. Abnormal PLAGL1 protein trafficking may occur in HCC.

    Conclusions:

    • PLAGL1 undergoes genomic and epigenetic changes in hepatocellular carcinoma.
    • The discrepancy between reduced PLAGL1 transcription and normal protein expression suggests post-transcriptional regulation or altered protein stability/trafficking.
    • Disruption of coordinated PLAGL1 and p53 gene expression and potential abnormal PLAGL1 protein trafficking contribute to hepatocarcinogenesis.